Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine IA vs IANB for Devitalized Mandibular Molar Extraction
NCT06439186Phase 4Completed
- Sponsor
- Necmettin Erbakan University
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lidocaine in procedural pain, sponsored by Necmettin Erbakan University. Primary endpoint: Visual Analog Scale. Started May 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06439186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06439186.